Real-time enrollment status for this myasthenia gravis clinical trial
Current Status
Active, Not Recruiting
Checked: September 2, 2026 at 3:32 PM UTC
| NCT Number | NCT06799247 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Myasthenia Gravis |
| Phase | PHASE3 |
| Target Enrollment | 100 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Cartesian Therapeutics |
| Last Updated on CT.gov | September 1, 2026 (Yesterday) |
As of September 2, 2026: Clinical trial NCT06799247 is currently active_not_recruiting participants. This phase3 study for myasthenia gravis is not currently accepting new participants at 23 locations across the United States. The study is sponsored by Cartesian Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06799247 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06799247 was last updated Yesterday (September 1, 2026). HelloStudys verifies this status automatically.